HGEN logo

Humanigen (HGEN) Cash From Financing

Annual CFF

$16.84 M
-$169.49 M-90.96%

December 31, 2022

Summary

Performance

1-Year Change

-90.96%

3-Year Change

+405.62%

5-Year Change

+39.38%

15-Year Change

+39.38%

HGEN Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$186.32 M
HGEN annual cash flow from financing activities is currently -90.96% below its historical high of $186.32 million

3-Year Low

$16.84 M
HGEN annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HGEN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HGEN next annual earnings announcement has not yet been scheduled

OtherHGENcash flowmetrics:

Annual CFI

-
HGEN annual cash flow from investing activities value is unknown

Annual CFO

-$76.70 M
HGEN annual cash flow from operations is -$76.70 million

Annual FCF

-$76.70 M
HGEN annual free cash flow is -$76.70 million

Annual CAPEX

-
HGEN annual capital expenditures value is unknown

Quarterly CFF

$0.00
$0.000.00%

March 31, 2023

Summary

Performance

3-Month Change

0%

1-Year Change

-100%

3-Year Change

-100%

5-Year Change

-100%

HGEN Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$95.60 M
HGEN quarterly cash flow from financing activities is currently -100.00% below its historical high of $95.60 million

3-Year Low

-$5.01 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HGEN previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HGEN next earnings announcement has not yet been scheduled

OtherHGENcash flowmetrics:

Quarterly CFI

-
HGEN quarterly cash flow from investing activities value is unknown

Quarterly CFO

-$7.06 M
HGEN quarterly cash flow from operations is -$7.06 million

Quarterly FCF

-$7.06 M
HGEN quarterly free cash flow is -$7.06 million

Quarterly CAPEX

-
HGEN quarterly capital expenditures value is unknown

TTM CFF

-$1.54 M
-$18.37 M-109.13%

March 31, 2023

Summary

Performance

3-Month Change

-109.13%

1-Year Change

-101.07%

3-Year Change

-140.32%

5-Year Change

-146.16%

HGEN TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$229.85 M
HGEN TTM cash flow from financing activities is currently -100.67% below its historical high of $229.85 million

3-Year Low

-$1.54 M
HGEN TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HGEN previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HGEN next earnings announcement has not yet been scheduled

OtherHGENcash flowmetrics:

TTM CFI

-
HGEN TTM cash flow from investing activities value is unknown

TTM CFO

-$64.31 M
HGEN TTM cash flow from operations is -$64.31 million

TTM FCF

-$64.31 M
HGEN TTM free cash flow is -$64.31 million

TTM CAPEX

-
HGEN TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

HGEN Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-91.0%-100.0%-101.1%
3 y3 years+405.6%-100.0%-140.3%
5 y5 years+39.4%-100.0%-146.2%

HGEN Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-91.0%at low-100.0%<-9999.0%-100.8%at low
5 y5-year-91.0%-80.2%-100.0%<-9999.0%-100.7%at low
alltimeall time-91.0%-120.9%-100.0%<-9999.0%-100.7%+747.5%

Humanigen Cash From Financing History

DateAnnualQuarterlyTTM
Mar 2023
-
$0.00(0.0%)
-$1.54 M(-109.1%)
Dec 2022
$16.84 M(-91.0%)
$0.00(-100.0%)
$16.84 M(-60.5%)
Sep 2022
-
-$5.01 M(-244.2%)
$42.61 M(-17.4%)
Jun 2022
-
$3.48 M(-81.1%)
$51.59 M(-64.1%)
Mar 2022
-
$18.37 M(-28.7%)
$143.72 M(-22.9%)
Dec 2021
$186.32 M(+35.5%)
$25.77 M(+549.9%)
$186.32 M(+16.1%)
Sep 2021
-
$3.97 M(-95.9%)
$160.55 M(-30.1%)
Jun 2021
-
$95.60 M(+56.8%)
$229.85 M(+16.1%)
Mar 2021
-
$60.98 M(>+9900.0%)
$197.91 M(+44.0%)
Dec 2020
$137.47 M(+4028.1%)
$1000.00(-100.0%)
$137.47 M(-0.4%)
Sep 2020
-
$73.27 M(+15.1%)
$138.00 M(+112.4%)
Jun 2020
-
$63.67 M(>+9900.0%)
$64.98 M(+1604.6%)
Mar 2020
-
$532.00 K(-0.6%)
$3.81 M(+14.5%)
Dec 2019
$3.33 M(-46.8%)
$535.00 K(+118.4%)
$3.33 M(+19.1%)
Sep 2019
-
$245.00 K(-90.2%)
$2.79 M(-49.9%)
Jun 2019
-
$2.50 M(+4900.0%)
$5.58 M(+52.5%)
Mar 2019
-
$50.00 K(>+9900.0%)
$3.65 M(-41.6%)
Dec 2018
$6.26 M(-48.2%)
$0.00(-100.0%)
$6.26 M(-20.2%)
Sep 2018
-
$3.02 M(+421.6%)
$7.84 M(-20.1%)
Jun 2018
-
$580.00 K(-78.1%)
$9.81 M(+6.3%)
Mar 2018
-
$2.65 M(+67.8%)
$9.23 M(-23.6%)
Dec 2017
$12.08 M
$1.58 M(-68.4%)
$12.08 M(-10.5%)
Sep 2017
-
$5.00 M(>+9900.0%)
$13.50 M(+58.8%)
Jun 2017
-
$0.00(-100.0%)
$8.50 M(-59.2%)
DateAnnualQuarterlyTTM
Mar 2017
-
$5.50 M(+83.2%)
$20.83 M(+35.9%)
Dec 2016
$15.33 M(-534.9%)
$3.00 M(>+9900.0%)
$15.33 M(-25.4%)
Sep 2016
-
$0.00(-100.0%)
$20.55 M(+80.4%)
Jun 2016
-
$12.33 M(>+9900.0%)
$11.39 M(-610.7%)
Mar 2016
-
$0.00(-100.0%)
-$2.23 M(-36.7%)
Dec 2015
-$3.53 M(-509.0%)
$8.22 M(-189.8%)
-$3.53 M(-72.9%)
Sep 2015
-
-$9.15 M(+607.5%)
-$13.03 M(+152.2%)
Jun 2015
-
-$1.29 M(-0.1%)
-$5.17 M(-1719.1%)
Mar 2015
-
-$1.29 M(+1.0%)
$319.00 K(-63.0%)
Dec 2014
$862.00 K(-99.1%)
-$1.28 M(-0.9%)
$862.00 K(-97.5%)
Sep 2014
-
-$1.29 M(-130.9%)
$34.11 M(-3.8%)
Jun 2014
-
$4.19 M(-657.2%)
$35.47 M(+15.0%)
Mar 2014
-
-$752.00 K(-102.4%)
$30.84 M(-67.9%)
Dec 2013
$96.01 M(+263.1%)
$31.97 M(>+9900.0%)
$96.01 M(+40.7%)
Sep 2013
-
$58.00 K(-113.4%)
$68.25 M(-5.3%)
Jun 2013
-
-$433.00 K(-100.7%)
$72.09 M(-20.6%)
Mar 2013
-
$64.41 M(+1429.6%)
$90.83 M(+243.5%)
Dec 2012
$26.44 M(>+9900.0%)
$4.21 M(+7.9%)
$26.44 M(+18.9%)
Sep 2012
-
$3.90 M(-78.7%)
$22.23 M(+21.3%)
Jun 2012
-
$18.31 M(>+9900.0%)
$18.33 M(>+9900.0%)
Mar 2012
-
$21.00 K
$21.00 K
Dec 2011
$34.00 K(-71.4%)
-
-
Dec 2010
$119.00 K(-97.6%)
-
-
Dec 2009
$4.99 M
-
-

FAQ

  • What is Humanigen annual cash flow from financing activities?
  • What is the all time high annual CFF for Humanigen?
  • What is Humanigen annual CFF year-on-year change?
  • What is Humanigen quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Humanigen?
  • What is Humanigen quarterly CFF year-on-year change?
  • What is Humanigen TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Humanigen?
  • What is Humanigen TTM CFF year-on-year change?

What is Humanigen annual cash flow from financing activities?

The current annual CFF of HGEN is $16.84 M

What is the all time high annual CFF for Humanigen?

Humanigen all-time high annual cash flow from financing activities is $186.32 M

What is Humanigen annual CFF year-on-year change?

Over the past year, HGEN annual cash flow from financing activities has changed by -$169.49 M (-90.96%)

What is Humanigen quarterly cash flow from financing activities?

The current quarterly CFF of HGEN is $0.00

What is the all time high quarterly CFF for Humanigen?

Humanigen all-time high quarterly cash flow from financing activities is $95.60 M

What is Humanigen quarterly CFF year-on-year change?

Over the past year, HGEN quarterly cash flow from financing activities has changed by -$18.37 M (-100.00%)

What is Humanigen TTM cash flow from financing activities?

The current TTM CFF of HGEN is -$1.54 M

What is the all time high TTM CFF for Humanigen?

Humanigen all-time high TTM cash flow from financing activities is $229.85 M

What is Humanigen TTM CFF year-on-year change?

Over the past year, HGEN TTM cash flow from financing activities has changed by -$145.26 M (-101.07%)